期刊文献+

脂肪因子Vaspin表达在急性冠脉综合征诊断及预后评估中的作用 被引量:6

The role of Vaspin expression in the diagnostic and prognostic evaluation of acute coronary syndrome
下载PDF
导出
摘要 目的:测定内脏脂肪特异性丝氨酸蛋白酶抑制剂(vaspin)、心肌肌钙蛋白T(cardiac troponin T,cTnT)以及B型尿钠肽前体(N-terminal pro-brain natriuretic peptide,NT-pro-BNP)在急性冠脉综合征组(acute coronary syndrome,ACS)、稳定性冠心病组和对照组中的表达水平,比较它们在各组的差异,为ACS临床诊断及预后评估提供新依据。方法:随机选取经冠状动脉造影术诊断明确ACS 158例,稳定性冠心病80例,非冠心病90例(对照组)。通过酶联免疫吸附实验法检测入组患者血清Vaspin浓度,同时检测cTnT和NT-pro-BNP的表达水平。采用单因素方差分析法比较ACS组、稳定性冠心病组和对照组之间Vaspin、cTnT、NT-pro-BNP的表达水平差异。随访术后2年内心源性死亡、心源性再入院以及再血管化治疗的发生情况,采用多因素Logistic回归分析法评估Vaspin表达水平与心血管不良预后的差异,最终综合评价Vaspin表达水平在ACS早期诊断及预后评估中的作用。结果:Vaspin表达:ACS组<稳定性冠心病组<对照组,差异具有统计学意义(P <0.01);cTnT表达:ACS组>稳定性冠心病组>对照组,差异具有统计学意义(P <0.01);NT-pro-BNP表达:ACS组>稳定性冠心病组>对照组,差异具有统计学意义(P <0.01)。Vaspin浓度与NT-pro-BNP和cTnT的水平呈显著负相关。Vaspin表达水平越低,发生心源性死亡、心源性再入院以及再血管化等不良事件的风险越高。结论:Vaspin在ACS中的表达水平显著低于稳定性冠心病和非冠心病患者,且与NT-pro-BNP和cTnT呈负相关。Vaspin是ACS的独立危险因素,Vaspin的表达水平越低则患者冠心病程度越重且预后越差。 Objective:Observing the expression of visceral fat-specific serine protease inhibitor(Vaspin),cardiac troponin T(cTnT and N-terminal pro-brain natriuretic peptide(NT-pro-BNP)in acute coronary syndrome(ACS),stable coronary heart disease and control to provide new basis of Vaspin for clinical diagnostic and prognostic evaluation of ACS. Methods:A total of 158 patients with ACS,80 patients with stable coronary heart disease and 90 patients without coronary heart disease were included. The expression of Vaspin was detected by enzyme-linked immunosorbent assay,while the levels of cTnT and NT-pro-BNP were detected at the same time. The expression levels of Vaspin,cTnT and NT-pro-BNP were analyzed and compared in three groups by one-way ANOVA. A 2-year follow-up of clinical outcomes including cardiac death,rehospitalization and revascularization was conducted and logistic analysis was used to evaluate the relationship between Vaspin level and clinical prognosis. Results:The results showed significant difference of Vaspin,cTnT and NT-pro-BNP among three groups(P < 0.01). The expression level of Vaspin was lowest in ACS group and highest in control group,while the expression level of cTnT and NT-pro-BNP were highest in ACS group and lowest in control group. There was significant negative correlations between Vaspin and NT-pro-BNP or cTnT. Furthermore,lower expression level of Vaspin indicated higher risk of cardiovascular adverse events,such as cardiac death,rehospitalization and revascularization. Conclusion:The expression level of Vaspin in ACS was significantly lower than that in stable and non-coronary heart disease,which was negatively correlated with NT-pro-BNP and cTnT. Vaspin is an independent risk factor for ACS,and the lower expression level of Vaspin,the worse prognosis of patients.
作者 张伟伟 程思源 张苑 孟浩宇 陈磊磊 Zhang Weiwei;Cheng Siyuan;Zhang Yuan;Meng Haoyu;Chen Leilei(Department of Cardiology .the First Affiliated Hospital of NMU 3 Nanjing 210029. China)
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2019年第2期224-227,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省六大人才高峰资助项目
关键词 VASPIN 急性冠脉综合征 心肌肌钙蛋白T B型尿钠肽前体 vaspin acute coronary syndrome cardiac troponin T N-terminal pro-brain natriuretic peptide
  • 相关文献

参考文献5

二级参考文献72

  • 1张涛,李自成.冠心病易损斑块的研究进展[J].临床心血管病杂志,2004,20(8):509-512. 被引量:18
  • 2Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin : a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005, 307:426-430.
  • 3Samal B, Sun Y, Steams G, et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colonyenhancing factor. Mol Cell Biol, 1994,14 : 1431-1437.
  • 4McGlothlin JR, Gao L, Lavoie T, et al. Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor. Biochem Genet,2005,43 : 127-141.
  • 5Kaser A, Ludwiczek O, Holzmann S, et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol, 2007,178 : 1748-1758.
  • 6Dahl TB, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation,2007,115 : 972-950.
  • 7Adya R, Tan BK, Punn A, et al. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovasc Res,2008,78 : 356-365.
  • 8Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res,2004,95 : 858-866.
  • 9Woods A, Brull D J, Humphries SE, et al. Genetics of inflammation and risk of coronary artery disease : the central role of interleukin-6. Eur Heart J,2000,21 : 1574-1583.
  • 10Pagano C, Pilon C, Olivieri M. Reduced plasma visfatin/pre-B cell eolony-enhancing factor in obesity is not related to insulin resistanee in humans. J Clin Endocrinol Metab,2006,91:3165-3170.

共引文献21

同被引文献68

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部